Skip to main content

Currently Skimming:

1 Introduction
Pages 1-10

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... , in his opening remarks, before the next outbreak, to define and implement an effective global architecture for recognizing and mitigating the threat of epidemic infectious diseases. 1 The planning committee's role was limited to planning the workshop.
From page 2...
... With encouragement and input from the World Bank; the World Health Organization (WHO) ; and the governments of the United Kingdom, United States, and West African countries; and support from various international and national organizations (Ford, Gates, Moore, Paul G
From page 3...
... The overarching objectives for the workshop include • Gathering diverse perspectives of informed stakeholders to foster construc tive discussion and facilitate the formation of collaborative solutions; • Characterizing needs and gaps in current approaches to addressing global infectious disease outbreaks and other public health threats, and describ ing barriers to addressing those needs; • Highlighting opportunities and potential approaches to improve the global system for addressing emerging threats; • Documenting key successes and lessons learned from past global infec tious disease outbreaks and other public health emergencies and how they may inform preparation and response to future outbreaks and emergen cies; and • Considering indicators and metrics that may be used to guide and assess the resilience of the global health infrastructure to future outbreaks and emergencies. Speakers and workshop participants will be invited to describe and examine systems and approaches to discover and develop medical products to address emerging threats.
From page 4...
... Regulatory review standards and systems: Address regulatory con •  siderations, including approaches to global regulatory harmonization and regulatory systems capacity. Manufacturing: Describe issues pertaining to supply chain management •  and product quality and integrity, and deployment of medical products.
From page 5...
... Governance A challenge when discussing governance in global health is who is governing whom. Global governance starts with national and subnational
From page 6...
... The global conversation needs to include financing instruments for health infrastructure, including human resources and health information systems. Resilient health systems include both the public health elements as well as the primary health care elements.
From page 7...
... Research and Development Pharmaceutical companies decisively shape the global research and development agenda and, as private-sector entities, they invest primarily where profitable markets exist. The system inherently tends to neglect innovation for diseases that disproportionately affect poor populations.
From page 8...
... rights, innovation, and public health, which she said presented a wealth of evidence that the current system of pharmaceutical development is fundamentally flawed, leaving significant health needs unmet because of its reliance on patents and commercial incentives for priority setting and financing of medical research and development.5 A global strategy and plan of action to address the IP concerns raised was approved by consensus at the World Health Assembly in 2008. Countries now need new proposals for financing and coordinating needs-driven research and development.
From page 9...
... She referred participants to the external reviews of the global responses to Ebola and pandemic H1N1 influenza outbreak, which note that member states have largely failed to implement core IHR capacities6 (Fineberg, 2015)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.